New test may help doctors pick better livers for transplant
NCT ID NCT07315204
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether measuring a substance called FMN in the fluid used to preserve donated livers can predict how well the liver will work after transplant. Researchers will collect samples from 850 liver transplant patients at multiple hospitals. The goal is to see if FMN levels can help doctors avoid using livers that might fail.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cleveland Clinic Foundation
RECRUITINGCleveland, Ohio, 44195, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can immune cells predict herpesvirus danger in transplant patients?
- Muscle quality on MRI may foretell liver transplant success
- Can removing the catheter early speed up liver surgery recovery?
- Better crystal ball for liver crisis: new scores put to the test
- A machine that keeps donor livers alive outside the body — could it transform transplantation?
- Frailty test could predict who survives liver transplant waiting list